KPIs & Operating Metrics(New)

Balance Sheet

Accounts Payables Accumulated Expenses Assets Capital Leases Cash & Current Investments Cash & Equivalents Common Equity Curent Deferred Tax Liability Current Assets Current Deferred Revenue Current Deferred Tax Assets Current Taxes Finished Goods Goodwill Goodwill & Intangibles Intangibles Inventory Liabilities and Shareholders Equity Liabilities from Discontinued Operations Long-Term Deferred Tax Long-Term Investments Minority Interest Non-Current Assets Non-Current Debt Non-Current Deferred Tax Liability Non-Current Deffered Revenue Operating Leases Other Accumulated Expenses Other Non-Current Assets Other Non-Current Liabilities Payables Pension Prepaid Assets Property, Plant & Equipment (Net)Raw Materials Receivables Retained Earnings Shareholder's Equity Short term Debt Short-term Investments Total Current Liabilities Total Debt Total Liabilities Total Non-Current Liabilities Treasury Shares Work In Process

Daily Values

Growth Metrics

Others

Charles River Laboratories International (CRL) Current Leases (2018)

Charles River Laboratories International (CRL) has 4 years of Current Leases data on record, last reported at $33.3 million in Q4 2021.

For Q4 2021, Current Leases changed N/A year-over-year to $33.3 million; the TTM value through Dec 2021 reached $33.3 million, changed N/A, while the annual FY2021 figure was $33.3 million, N/A changed from the prior year.
Current Leases reached $33.3 million in Q4 2021 per CRL's latest filing, up from $24.4 million in the prior quarter.
Across five years, Current Leases topped out at $33.3 million in Q4 2021 and bottomed at $3.2 million in Q4 2018.
Average Current Leases over 4 years is $20.0 million, with a median of $21.7 million recorded in 2019.